Internal Medicine, Endocrinology, Diabetes, & Metabolism · West Hollywood, CA
NPI
1093996720
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8700 Beverly Blvd, Becker-131
West Hollywood, CA, 90048
Phone (310) 248-6753
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$583K
1,207 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Peter Yuan prescribed most often to Medicare patients was Levothyroxine Sodium, with 251 prescriptions and refills. In total Peter Yuan wrote 1,207 Medicare prescriptions that cost $583K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 251 | 774 | 83 | $4,713 |
| Methimazole Generic | 195 | 623 | 72 | $3,581 |
| Forteo Teriparatide | 100 | 100 | 13 | $137K |
| Insulin Glargine-Yfgn Generic | 74 | 180 | 25 | $8,253 |
| Humalog Insulin Lispro | 66 | 177 | 21 | $17K |
| Hydrocortisone Generic | 54 | 173 | 18 | $3,638 |
| Humalog Kwikpen U-100 Insulin Lispro | 52 | 116 | 20 | $18K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 49 | 145 | 20 | $1,411 |
| Testosterone Generic | 45 | 115 | 21 | $3,986 |
| Cabergoline Generic | 26 | 70 | Under 11 | $717 |
| Cinacalcet Hcl Generic | 17 | 27 | Under 11 | $1,651 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 16 | 47 | Under 11 | $27K |
| Liothyronine Sodium Generic | 15 | 50 | Under 11 | $785 |
| Desmopressin Acetate Generic | 14 | 44 | Under 11 | $1,212 |
| Humalog Junior Kwikpen Insulin Lispro | 14 | 31 | Under 11 | $2,864 |
Brand drugs: 418 claims; generic drugs: 663 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Peter Yuan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.